Table 3. Associations of clinical and laboratory parameters with the progression of carotid atherosclerosis.
| Characteristics | OR (95% CI) | p-value |
|---|---|---|
| Age (yr) | 1.062 (1.044–1.080) | <0.001 |
| Male sex | 0.776 (0.490–1.229) | 0.280 |
| BMI (kg/m2) | 1.056 (1.007–1.107) | 0.023 |
| Alcohol use | 1.192 (0.847–1.676) | 0.313 |
| Smoking | 1.234 (0.798–1.908) | 0.344 |
| HTN | 1.170 (0.860–1.592) | 0.318 |
| DM duration, years | 1.022 (1.000–1.045) | 0.052 |
| HbA1c (%) | 1.075 (0.995–1.161) | 0.065 |
| Kitt (%/min) | 1.023 (0.877–1.192) | 0.773 |
| TC (mg/dL) | 1.005 (1.001–1.008) | 0.019 |
| TG (mg/dL) | 1.001 (0.999–1.002) | 0.289 |
| HDL-C (mg/dL) | 1.001 (0.992–1.010) | 0.856 |
| eGFR <60 mL/min/1.73m2 | 0.908 (0.530–1.556) | 0.726 |
| Total bilirubin (mg/dL) | 0.584 (0.392–0.870) | 0.008 |
| Statin use | 0.788 (0.511–1.215) | 0.280 |
| Aspirin use | 1.265 (0.846–1.893) | 0.252 |
OR, odds ratio; CI, confidence interval; BMI, body mass index; HTN, hypertension; DM, diabetes mellitus; HbA1c, glycated hemoglobin; Kitt, rate constant for plasma glucose disappearance; TC, total cholesterol; TG, triglycerides; HDL-C, high-density lipoprotein cholesterol; eGFR, estimated glomerular filtration rate test.